These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 16440328

  • 1. DNA vaccines: successes and limitations in cancer and infectious disease.
    Lowe DB, Shearer MH, Kennedy RC.
    J Cell Biochem; 2006 May 15; 98(2):235-42. PubMed ID: 16440328
    [Abstract] [Full Text] [Related]

  • 2. Human clinical trials of plasmid DNA vaccines.
    Liu MA, Ulmer JB.
    Adv Genet; 2005 May 15; 55():25-40. PubMed ID: 16291211
    [Abstract] [Full Text] [Related]

  • 3. DNA vaccination: antigen presentation and the induction of immunity.
    Shedlock DJ, Weiner DB.
    J Leukoc Biol; 2000 Dec 15; 68(6):793-806. PubMed ID: 11129646
    [Abstract] [Full Text] [Related]

  • 4. From plasmids to protection: a review of DNA vaccines against infectious diseases.
    Laddy DJ, Weiner DB.
    Int Rev Immunol; 2006 Dec 15; 25(3-4):99-123. PubMed ID: 16818367
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic cancer vaccines.
    Acres B, Paul S, Haegel-Kronenberger H, Calmels B, Squiban P.
    Curr Opin Mol Ther; 2004 Feb 15; 6(1):40-7. PubMed ID: 15011780
    [Abstract] [Full Text] [Related]

  • 6. Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21.
    Yamano T, Kaneda Y, Hiramatsu SH, Huang S, Tran AN, Giuliano AE, Hoon DS.
    Cancer Gene Ther; 2007 May 15; 14(5):451-9. PubMed ID: 17318199
    [Abstract] [Full Text] [Related]

  • 7. Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains.
    Ferrone CR, Perales MA, Goldberg SM, Somberg CJ, Hirschhorn-Cymerman D, Gregor PD, Turk MJ, Ramirez-Montagut T, Gold JS, Houghton AN, Wolchok JD.
    Clin Cancer Res; 2006 Sep 15; 12(18):5511-9. PubMed ID: 17000687
    [Abstract] [Full Text] [Related]

  • 8. Optimization and delivery of plasmid DNA for vaccination.
    Jechlinger W.
    Expert Rev Vaccines; 2006 Dec 15; 5(6):803-25. PubMed ID: 17184219
    [Abstract] [Full Text] [Related]

  • 9. Cancer vaccines: preclinical studies and novel strategies.
    Palena C, Abrams SI, Schlom J, Hodge JW.
    Adv Cancer Res; 2006 Dec 15; 95():115-45. PubMed ID: 16860657
    [Abstract] [Full Text] [Related]

  • 10. DNA vaccines: an historical perspective and view to the future.
    Liu MA.
    Immunol Rev; 2011 Jan 15; 239(1):62-84. PubMed ID: 21198665
    [Abstract] [Full Text] [Related]

  • 11. Cancer vaccines: challenges and outlook in the field.
    Paul S, Acres B, Limacher JM, Bonnefoy JY.
    IDrugs; 2007 May 15; 10(5):324-8. PubMed ID: 17487784
    [Abstract] [Full Text] [Related]

  • 12. Discovery and immunologic validation of new antigens for therapeutic cancer vaccines.
    Radvanyi L.
    Int Arch Allergy Immunol; 2004 Feb 15; 133(2):179-97. PubMed ID: 14764946
    [Abstract] [Full Text] [Related]

  • 13. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
    U'Ren L, Kedl R, Dow S.
    Cancer Gene Ther; 2006 Nov 15; 13(11):1033-44. PubMed ID: 16841080
    [Abstract] [Full Text] [Related]

  • 14. DNA vaccines.
    Donnelly JJ, Ulmer JB, Liu MA.
    Dev Biol Stand; 1998 Nov 15; 95():43-53. PubMed ID: 9855413
    [Abstract] [Full Text] [Related]

  • 15. Cancer vaccines: between the idea and the reality.
    Finn OJ.
    Nat Rev Immunol; 2003 Aug 15; 3(8):630-41. PubMed ID: 12974478
    [Abstract] [Full Text] [Related]

  • 16. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
    Durántez M, López-Vázquez AB, de Cerio AL, Huarte E, Casares N, Prieto J, Borrás-Cuesta F, Lasarte JJ, Sarobe P.
    Scand J Immunol; 2009 Feb 15; 69(2):80-9. PubMed ID: 19144076
    [Abstract] [Full Text] [Related]

  • 17. Cancer vaccines inducing antibody production: more pros than cons.
    Jensen-Jarolim E, Singer J.
    Expert Rev Vaccines; 2011 Sep 15; 10(9):1281-9. PubMed ID: 21919618
    [Abstract] [Full Text] [Related]

  • 18. Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model.
    Rinaldi M, Fioretti D, Iurescia S, Signori E, Pierimarchi P, Seripa D, Tonon G, Fazio VM.
    Biochem Biophys Res Commun; 2008 May 30; 370(2):279-84. PubMed ID: 18364239
    [Abstract] [Full Text] [Related]

  • 19. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A, Raff AB, Chiriva-Internati M, Chen SY, Kast WM.
    Immunol Rev; 2008 Apr 30; 222():316-27. PubMed ID: 18364011
    [Abstract] [Full Text] [Related]

  • 20. Cancer vaccines: a step towards prevention and treatment of cancer.
    Pandey M, Mathew A, Nair MK.
    Eur J Surg Oncol; 1999 Apr 30; 25(2):209-14. PubMed ID: 10218468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.